Abstract

ObjectivesTo investigate the diagnostic performance of the Kaiser score and apparent diffusion coefficient (ADC) to differentiate Breast Imaging Reporting and Data System (BI-RADS) Category 4 lesions at dynamic contrast-enhanced (DCE) MRI.MethodsThis was a single-institution retrospective study of patients who underwent breast MRI from March 2020 to June 2021. All image data were acquired with a 3-T MRI system. Kaiser score of each lesion was assigned by an experienced breast radiologist. Kaiser score+ was determined by combining ADC and Kaiser score. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic performance of Kaiser score+, Kaiser score, and ADC. The area under the curve (AUC) values were calculated and compared by using the Delong test. The differences in sensitivity and specificity between different indicators were determined by the McNemar test.ResultsThe study involved 243 women (mean age, 43.1 years; age range, 18–67 years) with 268 MR BI-RADS 4 lesions. Overall diagnostic performance for Kaiser score (AUC, 0.902) was significantly higher than for ADC (AUC, 0.81; p = 0.004). There were no significant differences in AUCs between Kaiser score and Kaiser score+ (p = 0.134). The Kaiser score was superior to ADC in avoiding unnecessary biopsies (p < 0.001). Compared with the Kaiser score alone, the specificity of Kaiser score+ increased by 7.82%, however, at the price of a lower sensitivity.ConclusionFor MR BI-RADS category 4 breast lesions, the Kaiser score was superior to ADC mapping regarding the potential to avoid unnecessary biopsies. However, the combination of both indicators did not significantly contribute to breast cancer diagnosis of this subgroup.

Highlights

  • Worldwide, breast cancer is the most frequently diagnosed malignant tumor in women and is currently the cause of most cancer-related death [1, 2]

  • We wonder whether integrating both indicators would improve the diagnostic performance in the assessment of Breast Imaging Reporting and Data System (BI-RADS) 4 breast lesions on CE-Magnetic Resonance Imaging (MRI)

  • The Kaiser score and the apparent diffusion coefficient (ADC) measured by the two readers showed excellent agreement

Read more

Summary

Introduction

Breast cancer is the most frequently diagnosed malignant tumor in women and is currently the cause of most cancer-related death [1, 2]. Dynamic contrast-enhanced (DCE) MRI is an effective tool in distinguishing malignant and benign breast lesions with high sensitivity [3–5]. The probability of malignancy of BI-RADS 4 lesions varies from 2% to 95% [5, 7], indicating that a large number of benign lesions would receive unnecessary invasive procedures. This will increase the psychological and financial burden for patients. Parenchymal Enhancement on Breast MRI: Impact on Diagnostic Performance. Li L, Roth R, Germaine P, Ren S, Lee M, Hunter K, et al Contrast-Enhanced Spectral Mammography (CESM) Versus Breast Magnetic Resonance Imaging (MRI): A Retrospective Comparison in 66 Breast Lesions.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call